PCI vs strategy for heart attack shock needing ECMO
Part of Heart & circulation clinical trials.
This study looks at the best way to reopen blocked heart arteries (using a stent procedure) in people who had a heart attack complicated by severe shock and need a life-support machine called VA-ECMO. It may help improve outcomes by testing which revascularization approach works best for multi-vessel blockages.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 19 years old.
- You had a heart attack (STEMI or NSTEMI) and then developed severe shock requiring VA-ECMO.
- Your shock started within the last 24 hours.
- You have multiple blocked arteries that doctors think can be treated with planned primary PCI (stents).
- There is no known cause of shock other than the heart attack (such as infection/sepsis, blood loss, or a different obstruction).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether using a life-support machine called ECMO (extra support for the heart and lungs) helps people who develop shock right after a heart attack. It aims to improve outcomes when blood flow is failing and organs may be struggling.
This trial tests if unloading the heart during ECMO support helps patients recover better from cardiogenic shock. It compares different ways to reduce the heart's workload.
This study tests whether adjusting the blood flow rate of an ECMO machine (which helps your heart pump) can improve blood flow to your organs and reduce stress on your heart during the critical early phase of cardiogenic shock. It aims to find the best ECMO settings to help you recover.
This trial tests whether using a small mechanical pump inside the heart plus careful monitoring with a special catheter can help people in shock after a heart attack. It compares this approach to standard care, aiming to improve survival and recovery.
This trial studies whether an “early” or more “conservative” approach to improving blood flow to the leg can prevent limb damage during a type of heart-lung machine called peripheral VA-ECMO. It may help reduce the risk of poor leg blood flow (ischemia) in people with severe heart failure-related shock.
This study looks at a heart attack complication called cardiogenic shock, where the heart is too weak to pump blood. People in this study will get a heart pump called VA-ECMO while having emergency angioplasty to open blocked heart arteries. The study will check if a certain treatment approach helps the heart recover.
Hear when a new Cardiogenic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.